Pre-ECTRIMS course

Course Programme "Patient reported outcomes: new perspectives"

Monday 11 October, 2021 (CET)

15.00-15.10 Welcome & Opening

Session 1: Understanding Multiple Sclerosis

• 15.10-15.30 Emerging environmental factors triggering MS: the gut-brain axis S. Baranzini, US
• 15.30-15.50 Immunosenescence and MS A.Bar-Or, Canada

15.50-16.05 Q&A

Session 2: Treating Multiple Sclerosis

• 16.05-16.25 Present and future of treating relapsing MS F.D. Lublin, US
• 16.25-16.45 Present and future of treating progression G. Comi, Italy
  

16.45-16.55 Break

• 16.55-17.15 Enhancing recovery: new approaches L. Leocani, Italy
• 17.15-17.35 MS and demyelinating diseases in children B. Banwell, US

17.35-17.50 Q&A

Session 3: Monitoring Multiple Sclerosis

• 17.50-18.10 Updated Role of MRI in Monitoring MS F. Barkhof, the Netherlands
• 18.10-18.30 Diagnosis and monitoring of cognitive functions in MS I.K. Penner, Germany
  

18.30-18.45 Q&A

18.45-19.30 Panel Discussion - Lessons learned from Covid-19 Faculty to be announced

19.30 End of Day 1

Tuesday 12 October, 2021

Session 4: Patient reported outcomes: new perspectives

• 15.01-15.20 The PROMS initiative P. Zaratin, Italy
• 15.20-15.40 Research, validation and development P. Vermersch, France
• 15.40-16.00 Role in clinical management R. McBurney, US

16.00-16.15 Q&A

16.15-16.25 Break

Session 5: MS Controversies 2021- The Future of MS Care

• 16.25-16.45 New evidence on the role of oligodendrocytes and OPCs in MS C. Lubetzki, France
• 16.45-17.05 Moving fluid biomarkers into the clinic M. Comabella, Sapin -J. Kuhle, Switzerland
• 17.05-18.00 Round Table: MS care in this and the next pandemic: transcontinental perspective J. Correale, Argentina; A. Cross, USA; G. Giovannoni, UK

18.00-18.15 Q&A

18.15-18.30 Wrap up and closing remarks

18:30 End of the Workshop

Registration is free of charge, however there are limited places available.

Download the Scientific Programme HERE.

Register NOW.